Aug. 3, 2021, 10:50 a.m.

(Forbes) Novavax stock has declined by almost 12% over the last week (five trading days), compared to the S&P 500 which has remained roughly flat over the same period. The stock is also down by almost 16% over the last month (21 trading days). There are likely a couple of factors driving the decline...

Login to grade this article.